Business
Firm Reiterates Commitment To Healthcare Delivery
Reckitt Benckiser Pharmaceutical Nigeria, says its vision and mission is to make a difference by providing innovation solutions for healthier lives and also ensure happier homes.
The Central Africa Regional Sales Representatives of the Pharmaceutical Company, Ben Kaiser who stated this last Thursday during the grand launching of Gaviscon in Port Harcourt, said the essence of the event was to introduce the brand in Port Harcourt and discuss the therapeutic challenge in Reflux disease and optimising the control of reflux in Nigeria through the use of Gaviscon.
Kaiser stated that Gaviscon which is the latest brand of Reckitt Benckiser is the only true suppressant that provides faster, effective and safer relief from heartburn.
According to him ,the pharmaceutical firm would continue to invest behind its brand in health and hygiene, saying that the firm Reckitt Benckiser has been in Nigeria for over 6o years with over 200 years heritage.
Kaiser boasted that the brand products of the company remains the best globally in healthcare worldwide.
”Strepils is the best and number one brand for sore throat relief and Durex is the number one for brand in sexual wellbeing, Nurofen, number one Analgesic brand in United Kingdom and heartburn relief brand in Europe and Australia”, he said.
He also explained that in Nigeria, Dettol is number one in medicated soap and antic septic liquid, Airwick is number one in airfreshners ,Harpic ,the number one and the best in lavatory care and Jik is the number one whitening bleach in Nigeria.
He however said, Rackitt Benckiser Nigeria’s Journey into healthcare started with the launch of Strepils in 2008 and Durex in 2001.
Presenting a paper at the occasion, A consultant Gastroenterologist with the University of Port Harcourt, Dr. Ipalibo S. Wokoma said Gaviscon, the reflux suppressant could be administered to a pregnant and breastfeeding mothers.
Dr Wokoma explained that the reflux suppressant forms a strong, long lasting raft in the stomach and effectively suppressing reflux into the esophagus.
According to him, the new brand rapidly soothes the burning pain of heartburn in three minutes and provides relief for up to four hours, adding that the majority of reflux episodes occur in the first three hours after eating.
The prominent attendees at the occasion were Gastroenterologists, Gynaecologist, General physicians and pharmacists.
Cornerstone of Financial Services
A survey of more than 1 000 global finance leaders undertaken by digital payment network Ripple shows that 72% of respondents believe they need to offer a digital asset solution to remain competitive.
According to Ripple, leaders from the banking, fintech, corporate and asset management sector have made it clear that the “digital asset revolution is happening now”.
“Digital assets are quickly becoming a cornerstone of financial services, underpinned by progressive regulation, growing interest from Tier-1 banks, a steady consumer shift from banks to fintech providers, and booming stablecoin adoption,” Ripple says.
The survey was conducted in early 2026 and the findings released in March.
Stablecoin Boon or Bane?
Ripple has experienced significant success in the stablecoin sector since launching its Ripple USD (RLUSD) stablecoin in 2024.
With a market cap of $1.56 billion, it is considered a major regulated player in the market.
No doubt the platform was pleased to learn through its own survey that financial leaders were most bullish about stablecoins.
Roughly three-quarters of respondents believed they could boost cash-flow efficiency and unlock trapped working capital.
Ripple noted that finance leaders were thinking about stablecoins as more than “just a new way to execute payments”; instead, they viewed them as effective tools for treasury management.
In March 2026, Ripple began testing a new trade finance model built around RLUSD in a bid to increase the speed of cross-border payments.
The pilot initiative, developed alongside supply chain finance company Unloq [https://unloq.com], is running on the XRP Ledger inside a testing framework developed by the Monetary Authority of Singapore.
The Asian city-state is one of the platform’s biggest growth markets.
The idea behind the project is to see whether stablecoin-based settlement can streamline trade finance, too often hampered by reliance on intermediaries and slow reconciliation.
The only potential drawback is that if the initiative takes off, the Ripple to USD price could be negatively affected.
Ripple has always championed its native XRP token as a bridge asset, the “middleman” in the process of a financial institution turning dollars in the US into pounds in the UK, for example.
Ripple converts dollars into XRP and then back into pounds.
If RLUSD can do exactly the same thing, questions will be asked about XRP’s relevance.
That is a bridge Ripple will have to cross if it gets to that point.
Tokenisation Partners
Another interesting finding from Ripple’s survey is that most banks and asset managers are seeking tokenisation partners to help execute their strategies.
Some 89% of respondents said digital asset storage and custody were top priority. “Token servicing/lifecycle management also ranks highly for banks at 82%, while asset managers place greater emphasis on primary distribution at 80%,” Ripple found.
The survey also revealed that just more than half of fintechs and financial institutions want an infrastructure provider that can offer a “one-stop-shop solution”. This rose to 71% among corporate financial leaders.
Ripple attributes this to institutions and firms wanting uncomplicated, cohesive systems.
Infrastructure Rules
In its final analysis, Ripple says companies across the board are looking for partners and solutions that are “secure, compliant, battle-tested and that enable growth and execution”.
“The message is clear: infrastructure decisions made today will shape competitive positioning tomorrow.”
No surprise that this is precisely where Ripple is placing much of its focus.
